/QUIA.ST
QUIA.ST Stock - Quia Pharma AB (publ)
Healthcare|BiotechnologySTO
$0.00-16.67%
$0.00 (-16.67%) • Dec 15
54
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.98
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for QUIA.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.56
52W High$0.03
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $460,000 | $4.37M | $5.57M | $216,000 | $1.86M |
| Gross Profit | $460,000 | $2.17M | $3.33M | $527,000 | $-2,988,000 |
| Gross Margin | 100.0% | 49.6% | 59.8% | 244.0% | -160.6% |
| Operating Income | $-28,665,000 | $-15,512,000 | $-15,794,000 | $-17,568,000 | $-24,934,000 |
| Net Income | $-28,929,000 | $-16,523,000 | $-24,384,000 | $-22,431,000 | $-27,710,000 |
| Net Margin | -6288.9% | -377.8% | -437.5% | -10384.7% | -1489.0% |
| EPS | $-0.08 | $-0.22 | $-11.34 | $-31.92 | $-67.07 |
Company Overview
QUIA PHARMA AB engages in the research, development, and commercialization of drug delivery system. Its product, Uni-Qleaver®, uses releasable pegylation technology that eliminates potential drawbacks and adjusts the drug's half-life. The company was founded by Marek Kwiatkowski and is headquartered in Uppsala, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
QUIA.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q2 2024
EPS Surprise History
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q1 24
No data
Q2 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | Jun 14, 2024 | — | $-0.01 | — | — |
Q1 2024 | Mar 31, 2024 | — | $-0.01 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.04 | — | — |
Q3 2023 | Sep 29, 2023 | — | $-0.04 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.76 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.76 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-2.47 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-3.03 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-3.62 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-6.96 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-9.45 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-7.91 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-7.62 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-6.75 | — | — |
Q1 2021 | Feb 26, 2021 | — | $-18.19 | — | — |
Q4 2020 | Nov 28, 2020 | — | $-20.76 | — | — |
Q3 2020 | Aug 26, 2020 | — | $-18.08 | — | — |
Q2 2020 | May 27, 2020 | — | $-17.97 | — | — |
Q1 2020 | Feb 28, 2020 | — | $-17.99 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-22.31 | — | — |
Latest News
Loading news...
Frequently Asked Questions about QUIA.ST
What is QUIA.ST's current stock price?
Quia Pharma AB (publ) (QUIA.ST) is currently trading at $0.00 per share. The stock has moved -16.67% today.
What is the analyst price target for QUIA.ST?
No analyst price targets are currently available for this stock.
What sector is Quia Pharma AB (publ) in?
Quia Pharma AB (publ) operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the STO exchange.
What is QUIA.ST's market cap?
Quia Pharma AB (publ) has a market capitalization of $0.00 billion, making it a small-cap company.
Does QUIA.ST pay dividends?
No, Quia Pharma AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAPTA.ST
Aptahem AB (publ)
$1.12
Mkt Cap: $0.0B
CMH.ST
Chordate Medical Holding AB (publ)
$0.61
Mkt Cap: $0.0B
FLUI.ST
Fluicell AB (publ)
$11.30
Mkt Cap: $0.0B
GABA.ST
Gabather AB (publ)
$0.03
Mkt Cap: $0.0B
LIDDS.ST
LIDDS AB (publ)
$0.04
Mkt Cap: $0.0B
PLUN.ST
ProstaLund AB (publ)
$0.21
Mkt Cap: $0.0B
S2M.ST
S2Medical AB (publ)
$0.01
Mkt Cap: $0.0B
SPERM.ST
Spermosens AB
$0.01
Mkt Cap: $0.0B
STABL.ST
Stayble Therapeutics AB (publ)
$0.21
Mkt Cap: $0.0B
Explore stocks similar to QUIA.ST for comparison